tiprankstipranks
Repare Therapeutics Inc (RPTX)
NASDAQ:RPTX
US Market

Repare Therapeutics (RPTX) Financial Statements

285 Followers

Repare Therapeutics Financial Overview

Repare Therapeutics's market cap is currently ―. The company's EPS TTM is $-1.098; its P/E ratio is -3.55; Repare Therapeutics is scheduled to report earnings on August 8, 2024, and the estimated EPS forecast is $-0.87. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue$ 52.40M$ -32.41M---
Gross Profit-----
EBIT$ 10.82M$ -30.87M$ -35.18M$ -8.84M$ -34.75M
EBITDA$ 11.32M$ -30.36M$ -36.56M$ -10.42M$ -36.15M
Net Income Common Stockholders$ 13.16M$ -28.03M$ -18.88M$ -11.95M$ -34.94M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 237.00M$ 223.63M$ 250.07M$ 280.69M$ 314.12M
Total Assets$ 263.08M$ 253.90M$ 286.41M$ 301.59M$ 336.31M
Total Debt$ 2.78M$ 3.41M$ 3.92M$ 4.55M$ 5.04M
Net Debt$ -234.22M$ -220.22M$ -246.15M$ -276.15M$ -309.09M
Total Liabilities$ 31.13M$ 41.82M$ 53.04M$ 56.17M$ 85.06M
Stockholders Equity$ 231.95M$ 212.08M$ 233.37M$ 245.41M$ 251.24M
Cash Flow-
Free Cash Flow$ 11.93M$ -28.55M$ -32.87M$ -35.41M$ -32.26M
Operating Cash Flow$ 11.93M$ -28.16M$ -32.87M$ -34.35M$ -31.79M
Investing Cash Flow$ -20.32M$ 31.88M$ 24.50M$ 28.35M$ -6.69M
Financing Cash Flow$ 375.00K$ 105.00K$ 284.00K$ 40.00K$ 413.00K
Currency in USD

Repare Therapeutics Earnings and Revenue History

Repare Therapeutics Debt to Assets

Repare Therapeutics Cash Flow

Repare Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis